64 related articles for article (PubMed ID: 2211022)
1. 31P magnetic resonance spectroscopy of animal uveal melanoma.
Kurhanewicz J; Winguth SD; Char DH; Kaleta S; Kindy-Degnan N; Swift PS; Stauffer PR; Wendland MF; Lovato A; Chang LH
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1745-53. PubMed ID: 2211022
[TBL] [Abstract][Full Text] [Related]
2. 31P magnetic resonance spectroscopy (MRS) of experimental orbital myositis.
Winguth S; Kurhanewicz J; Wang ML; Quivey JM; James TL; Char DH
Invest Ophthalmol Vis Sci; 1991 Jul; 32(8):2417-22. PubMed ID: 2071353
[TBL] [Abstract][Full Text] [Related]
3. 31P magnetic resonance spectroscopy after combined hyperthermia and radiation.
Kurhanewicz J; Char DH; Stauffer P; Quivey JM; James TL
Curr Eye Res; 1994 Feb; 13(2):151-6. PubMed ID: 8194362
[TBL] [Abstract][Full Text] [Related]
4. Concurrent versus sequential application of ferromagnetic hyperthermia and 125I brachytherapy of melanoma in an animal model.
Mieler WF
Trans Am Ophthalmol Soc; 1997; 95():611-28. PubMed ID: 9440189
[TBL] [Abstract][Full Text] [Related]
5. Metabolic signatures associated with a NAD synthesis inhibitor-induced tumor apoptosis identified by 1H-decoupled-31P magnetic resonance spectroscopy.
Muruganandham M; Alfieri AA; Matei C; Chen Y; Sukenick G; Schemainda I; Hasmann M; Saltz LB; Koutcher JA
Clin Cancer Res; 2005 May; 11(9):3503-13. PubMed ID: 15867253
[TBL] [Abstract][Full Text] [Related]
6. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
[TBL] [Abstract][Full Text] [Related]
7. Correlations between 31P-NMR spectroscopy and tissue O2 tension measurements in a murine fibrosarcoma.
Vaupel P; Okunieff P; Kallinowski F; Neuringer LJ
Radiat Res; 1989 Dec; 120(3):477-93. PubMed ID: 2594969
[TBL] [Abstract][Full Text] [Related]
8. Assessment of in situ renal transplant viability by 31P-MRS: experimental study in canines.
Bretan PN; Vigneron DB; Hricak H; Price DC; Yen TS; Luo JA; Tanagho EA; James TL
Am Surg; 1993 Mar; 59(3):182-7. PubMed ID: 8386489
[TBL] [Abstract][Full Text] [Related]
9. Effects of pentobarbital anesthesia on the energy metabolism of murine tumors studied by in vivo 31P nuclear magnetic resonance spectroscopy.
Okunieff P; Rummeny E; Vaupel P; Skates S; Willett C; Neuringer LJ; Suit HD
Radiat Res; 1988 Aug; 115(2):361-72. PubMed ID: 3406373
[TBL] [Abstract][Full Text] [Related]
10. Effect of cytochrome P450 induction on phosphorus metabolites and proton relaxation times measured by in vivo 31P-magnetic resonance spectroscopy and 1H-magnetic resonance relaxometry in human liver.
Block W; Reichel C; Träber F; Skodra T; Lamerichs R; Kreft B; Spengler U; Sauerbruch T; Schild HH
Hepatology; 1997 Dec; 26(6):1587-91. PubMed ID: 9398002
[TBL] [Abstract][Full Text] [Related]
11. Role of nuclear magnetic resonance spectroscopy (MRS) in cancer diagnosis and treatment: 31P, 23Na, and 1H MRS studies of three models of pancreatic cancer.
Kaplan O; Kushnir T; Askenazy N; Knubovets T; Navon G
Cancer Res; 1997 Apr; 57(8):1452-9. PubMed ID: 9108445
[TBL] [Abstract][Full Text] [Related]
12. Effects of chemotherapy by 1,3-bis(2-chloroethyl)-1-nitrosourea on single-quantum- and triple-quantum-filtered 23Na and 31P nuclear magnetic resonance of the subcutaneously implanted 9L glioma.
Winter PM; Poptani H; Bansal N
Cancer Res; 2001 Mar; 61(5):2002-7. PubMed ID: 11280759
[TBL] [Abstract][Full Text] [Related]
13. Measurements of in vivo 31P nuclear magnetic resonance spectra in neuroectodermal tumors for the evaluation of the effects of chemotherapy.
Naruse S; Hirakawa K; Horikawa Y; Tanaka C; Higuchi T; Ueda S; Nishikawa H; Watari H
Cancer Res; 1985 Jun; 45(6):2429-33. PubMed ID: 3986784
[TBL] [Abstract][Full Text] [Related]
14. Response of radiation-induced fibrosarcoma-1 in mice to cyclophosphamide monitored by in vivo 31P nuclear magnetic resonance spectroscopy.
Li SJ; Wehrle JP; Rajan SS; Steen RG; Glickson JD; Hilton J
Cancer Res; 1988 Sep; 48(17):4736-42. PubMed ID: 3409214
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of thermal damage after hyperthermia on murine experimental tumor by 31P-NMR spectroscopy--correlation between ATP and growth curve].
Kitada N; Akagi K; Uda M; Hasegawa T; Oshima T; Tanaka Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):669-73. PubMed ID: 1508639
[TBL] [Abstract][Full Text] [Related]
16. Microwave hyperthermia for choroidal melanoma in rabbits.
Swift PS; Stauffer PR; Fries PD; Kaleta-Michaels S; Murray T; Sneed PK; Phillips TL; Char DH
Invest Ophthalmol Vis Sci; 1990 Sep; 31(9):1754-60. PubMed ID: 2211023
[TBL] [Abstract][Full Text] [Related]
17. Murine mammary tumor response to hyperthermia and radiotherapy evaluated by in vivo 31P-nuclear magnetic resonance spectroscopy.
Sijens PE; Bovée WM; Seijkens D; Koole P; Los G; van Rijssel RH
Cancer Res; 1987 Dec; 47(24 Pt 1):6467-73. PubMed ID: 3677087
[TBL] [Abstract][Full Text] [Related]
18. 31P-nuclear magnetic resonance studies of the effect of recombinant human interleukin 1 alpha on the bioenergetics of RIF-1 tumors.
Constantinidis I; Braunschweiger PG; Wehrle JP; Kumar N; Johnson CS; Furmanski P; Glickson JD
Cancer Res; 1989 Nov; 49(22):6379-82. PubMed ID: 2804984
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic cell cytotoxin tirapazamine induces acute changes in tumor energy metabolism and pH: a 31P magnetic resonance spectroscopy study.
Aboagye EO; Dillehay LE; Bhujwalla ZM; Lee DJ
Radiat Oncol Investig; 1998; 6(6):249-54. PubMed ID: 9885940
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the 31P nuclear magnetic resonance spectrum from human melanoma tumors implanted in nude mice.
Corbett RJ; Nunnally RL; Giovanella BC; Antich PP
Cancer Res; 1987 Oct; 47(19):5065-9. PubMed ID: 3621191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
